Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
IMG Pharma has entered into a definitive agreement to acquire Matsumoto Pharmaceutical, a pharmacy business in Japan. IMG Pharma acquisitions focus on expanding healthcare distribution and retail pharmacy capabilities, while Matsumoto Pharmaceutical operates in Japan’s pharmaceutical supply and pharmacy market. The IMG Pharma acquisitions are positioned as a strategic acquisition to strengthen presence in the Japanese pharmacy sector and support long-term growth in healthcare M&A. The merger acquisition is announced and structured as a strategic acquisition, with deal size undisclosed and completion subject to customary closing conditions.
Source
Read full article on prnewswire.comvia GN - entered into definitive agreement · April 27, 2026
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026